secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2022-08-17T23:59:59+00:00
Accession:  0001104659-22-092239
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio (TELA) raises ~$34.2M in public offering of 4.6M shares at $8.00
-------------------------------------------------------------------------

- Underwriting agreement with Lake Street Capital Markets for 4M shares at $8.00/share; option for 600K additional shares exercised in full.
- Net proceeds expected to be approximately $34.2 million after underwriting discounts and offering expenses.
- Proceeds intended for working capital, general corporate purposes, including R&D, manufacturing, and potential acquisitions.
- Offering expected to close on August 18, 2022, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465922092239/0001104659-22-092239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465922092239/tm2223653d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-092239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer